---
title: "Nectero Medical granted Breakthrough Therapy designation for the Nectero EAST system to treat infrarenal AAA"
date: "2023-11-01T23:25:59.000Z"
publishedDate: "1 novembre 2023"
summary: "Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Nectero Endovascular Aneurysm Stabilisation Treatment (Nectero EAST) system to treat patients with infrarenal abdominal aortic aneurysms (AAAs), maximum diameter 3.5–5cm. Nectero Medical is initiating a randomised, controlled Phase II/III clinical trial (stAAAble) to evaluate the product&#8217;s [&#8230;] The post Nectero Medical granted Breakthrough Therapy designation for the Nectero EAST system to treat infrarenal AAA appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/nectero-medical-granted-breakthrough-therapy-designation-for-the-nectero-east-system-to-treat-infrarenal-aaa/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-11-01-nectero-medical-granted-breakthrough-therapy-designation-for-the-nectero-east-system-to-treat-infrarenal-aaa"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2021/09/Nectero-Medical-logo-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/nectero-medical-granted-breakthrough-therapy-designation-for-the-nectero-east-system-to-treat-infrarenal-aaa/"
---

![Nectero Medical granted Breakthrough Therapy designation for the Nectero EAST system to treat infrarenal AAA](https://vascularnews.com/wp-content/uploads/sites/7/2021/09/Nectero-Medical-logo-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/nectero-medical-granted-breakthrough-therapy-designation-for-the-nectero-east-system-to-treat-infrarenal-aaa/*

## L’essentiel

Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Nectero Endovascular Aneurysm Stabilisation Treatment (Nectero EAST) system to treat patients with infrarenal abdominal aortic aneurysms (AAAs), maximum diameter 3.5–5cm. Nectero Medical is initiating a randomised, controlled Phase II/III clinical trial (stAAAble) to evaluate the product&#8217;s [&#8230;] The post Nectero Medical granted Breakthrough Therapy designation for the Nectero EAST system to treat infrarenal AAA appeared first on Vascular News .

## Lien source

https://vascularnews.com/nectero-medical-granted-breakthrough-therapy-designation-for-the-nectero-east-system-to-treat-infrarenal-aaa/
